Sandip Patel

Title(s)Associate Clinical Professor, Medicine
SchoolVc-health Sciences-schools
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-Grade Neuroendocrine Neoplasm Cohort. Cancer. 2021 Apr 21. Patel SP, Mayerson E, Chae YK, Strosberg J, Wang J, Konda B, Hayward J, McLeod CM, Chen HX, Sharon E, Othus M, Ryan CW, Plets M, Blanke CD, Kurzrock R. PMID: 33882143.
      View in: PubMed   Mentions: 1     Fields:    
    2. IMpower 132: Loses Power at the Finish Line. J Thorac Oncol. 2021 Apr; 16(4):512-514. Patel SP, Kelly K. PMID: 33781439.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Commentary: Induction Immunotherapy: Intriguing Initiative for Investigation. Semin Thorac Cardiovasc Surg. 2021 Mar 01. Patel SP, Onaitis M. PMID: 33662553.
      View in: PubMed   Mentions:    Fields:    
    4. Author Correction: Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions. Sci Rep. 2020 Nov 20; 10(1):20641. Gago-Dominguez M, Matabuena M, Redondo CM, Patel SP, Carracedo A, Ponte SM, Martínez ME, Castelao JE. PMID: 33219311.
      View in: PubMed   Mentions:    Fields:    
    5. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign? CA Cancer J Clin. 2021 01; 71(1):34-46. Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. PMID: 32997807.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    6. Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. Mol Oncol. 2021 01; 15(1):67-79. Charo LM, Eskander RN, Okamura R, Patel SP, Nikanjam M, Lanman RB, Piccioni DE, Kato S, McHale MT, Kurzrock R. PMID: 32881280.
      View in: PubMed   Mentions: 1     Fields:    
    7. Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clin Cancer Res. 2020 10 15; 26(20):5358-5367. Glisson BS, Leidner RS, Ferris RL, Powderly J, Rizvi NA, Keam B, Schneider R, Goel S, Ohr JP, Burton J, Zheng Y, Eck S, Gribbin M, Streicher K, Townsley DM, Patel SP. PMID: 32816951.
      View in: PubMed   Mentions: 9     Fields:    
    8. Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions. Sci Rep. 2020 08 06; 10(1):13203. Gago-Dominguez M, Matabuena M, Redondo CM, Patel SP, Carracedo A, Ponte SM, Martínez ME, Castelao JE. PMID: 32764699.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    9. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A. 2020 08 18; 117(33):20159-20170. Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, Agrawal K, Gonzalez GM, Wang Y, Patel SP, Rana TM. PMID: 32747553.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    10. Rapid onset type 1 diabetes with anti-PD-1 directed therapy. Oncotarget. 2020 Jul 14; 11(28):2740-2746. Yun K, Daniels G, Gold K, Mccowen K, Patel SP. PMID: 32733645.
      View in: PubMed   Mentions: 1     Fields:    
    11. Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Response. Clin Cancer Res. 2020 05 15; 26(10):2434. Patel SP, Othus M, Chae YK, Kurzrock R, S1609 Team . PMID: 32414761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020 03; 579(7800):567-574. Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Knight R. PMID: 32214244.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    13. Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 09; 21(5):e435-e444. Naidoo J, Nishino M, Patel SP, Shankar B, Rekhtman N, Illei P, Camus P. PMID: 32576443.
      View in: PubMed   Mentions: 5     Fields:    
    14. Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation. Oncologist. 2020 07; 25(7):562-e1012. Patel SP, Pakkala S, Pennell NA, Reckamp KL, Lanzalone S, Polli A, Tarazi J, Robert-Vizcarrondo F. PMID: 32048771.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    15. A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors. Clin Cancer Res. 2020 05 15; 26(10):2290-2296. Patel SP, Othus M, Chae YK, Giles FJ, Hansel DE, Singh PP, Fontaine A, Shah MH, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, McLeod C, Chen HX, Sharon E, Mayerson E, Ryan CW, Plets M, Blanke CD, Kurzrock R. PMID: 31969335.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    16. Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade. Oncology. 2020; 98(2):123-130. Galant-Swafford J, Troesch A, Tran L, Weaver A, Doherty TA, Patel SP. PMID: 31665718.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun; 3(2):235-237. Tyan A, Patel SP, Block S, Hughes T, McCowen KC. PMID: 31193884.
      View in: PubMed   Mentions:
    18. GABABR-Mediated Paraneoplastic Limbic Encephalitis Due To Thymic Small Cell Carcinoma. J Gen Intern Med. 2019 08; 34(8):1658-1661. Bordin-Wosk T, Patel SP, Horman SF. PMID: 31062226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. JCO Precis Oncol. 2019; 3. Kato S, Okamura R, Mareboina M, Lee S, Goodman A, Patel SP, Fanta PT, Schwab RB, Vu P, Raymond VM, Lanman RB, Sicklick JK, Lippman SM, Kurzrock R. PMID: 31058253.
      View in: PubMed   Mentions:
    20. Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes. Breast. 2019 Apr; 44:29-32. Tray N, Taff J, Singh B, Suh J, Ngo N, Kwa M, Troxel AB, Chae YK, Kurzrock R, Patel SP, Sharon E, Denkert C, Ross JS, Adams S. PMID: 30609392.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors. J Immunother Cancer. 2018 09 25; 6(1):93. Tran B, Carvajal RD, Marabelle A, Patel SP, LoRusso PM, Rasmussen E, Juan G, Upreti VV, Beers C, Ngarmchamnanrith G, Schöffski P. PMID: 30253804.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    22. Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune-Checkpoint Inhibitors for Cancer Treatment. Oncologist. 2018 10; 23(10):1236-1241. Patel NS, Oury A, Daniels GA, Bazhenova L, Patel SP. PMID: 29769383.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy. Clin Cancer Res. 2017 Oct 01; 23(19):5729-5736. Khagi Y, Goodman AM, Daniels GA, Patel SP, Sacco AG, Randall JM, Bazhenova LA, Kurzrock R. PMID: 28972084.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    24. Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. . 2017 11; 16(11):2598-2608. Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R. PMID: 28835386.
      View in: PubMed   Mentions:
    25. Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models. Clin Cancer Res. 2017 Nov 01; 23(21):6661-6672. Engstrom LD, Aranda R, Lee M, Tovar EA, Essenburg CJ, Madaj Z, Chiang H, Briere D, Hallin J, Lopez-Casas PP, Baños N, Menendez C, Hidalgo M, Tassell V, Chao R, Chudova DI, Lanman RB, Olson P, Bazhenova L, Patel SP, Graveel C, Nishino M, Shapiro GI, Peled N, Awad MM, Jänne PA, Christensen JG. PMID: 28765324.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    26. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. Oncologist. 2017 06; 22(6):631-637. Sharabi A, Kim SS, Kato S, Sanders PD, Patel SP, Sanghvi P, Weihe E, Kurzrock R. PMID: 28550027.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    27. Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. Clin Cancer Res. 2017 Sep 01; 23(17):5101-5111. Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R. PMID: 28539465.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    28. Next generation predictive biomarkers for immune checkpoint inhibition. Cancer Metastasis Rev. 2017 03; 36(1):179-190. Khagi Y, Kurzrock R, Patel SP. PMID: 27873079.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    29. Impact of Integrating Rumke Statistics to Assist with Choosing Between Automated Hematology Analyzer Differentials vs Manual Differentials. J Appl Lab Med. 2017 Jan 01; 1(4):357-364. Stephens L, Hintz-Prunty W, Bengtsson HI, Proudfoot JA, Patel SP, Broome HE. PMID: 33636799.
      View in: PubMed   Mentions: 1     Fields:    
    30. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nat Rev Clin Oncol. 2017 04; 14(4):203-220. Goodman A, Patel SP, Kurzrock R. PMID: 27805626.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    31. Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. NPJ Genom Med. 2016; 1. Ikeda S, Goodman AM, Cohen PR, Jensen TJ, Ellison CK, Frampton G, Miller V, Patel SP, Kurzrock R. PMID: 27942391.
      View in: PubMed   Mentions:
    32. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clin Cancer Res. 2016 Nov 15; 22(22):5497-5505. Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Patel SP, Harismendy O, Ikeda M, Parker BA, Kurzrock R. PMID: 27185373.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    33. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. Oncotarget. 2015 Oct 20; 6(32):32602-9. Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R. PMID: 26418953.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy. . 2015 Apr; 14(4):847-56. Patel SP, Kurzrock R. PMID: 25695955.
      View in: PubMed   Mentions:
    35. Designing effective vaccines for colorectal cancer. Immunotherapy. 2014; 6(8):913-26. Patel SP, Osada T, Lyerly HK, Morse MA. PMID: 25313570.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models. Cancer Immunol Immunother. 2013 Jun; 62(6):1011-9. Patel SP, Bristol A, Saric O, Wang XP, Dubeykovskiy A, Arlen PM, Morse MA. PMID: 23591984.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    Sandip's Networks
    Concepts (161)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (40)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.0.0-839-g49dc76ac on PROFILES-PWEB02.

    Copyright © The Regents of the University of California